Award
NIH Reporter #3U01AI158460-05S1
Mechanistic clinical trial of blocking the IL-4/13 axis in asthmatics precision phenotyped in an aeroallergen challenge chamber before, during and after receipt of dupilumab
Recipient
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Award Amount
$490,019.00
Ceiling
$490,019.00
Awarded
August 19, 2026
Identifier
3U01AI158460-05S1
A clinical trial funded by NIAID to investigate the effects of dupilumab on allergic asthma and rhinitis through detailed mechanistic studies.
Description
This project involves a mechanistic clinical trial to study the effects of dupilumab on allergic asthma and rhinitis, with detailed assessments pre-, during, and post-treatment, including mechanistic studies of airway and systemic compartments.